bibliographic entry 12498236 [be/12498236]
https://w3id.org/oc/corpus/be/12498236

is a
content
  • Zhang, W, Azuma, M, Lurje, G, Gordon, MA, Yang, D, Pohl, A. Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study). Anticancer Res (2010) 30: 4209–17. PMID: 21036743
references